Analystreport

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) was downgraded by analysts at Bank of America Corp from a "buy" rating to an "underperform" rating. They now have a $15.00 price target on th...

Ironwood Pharmaceuticals, Inc. - Class A  (IRWD) 
Last ironwood pharmaceuticals, inc. - class a earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.ironwoodpharma.com